March 27, 2025
We launched Float for one simple reason: to modernize the specialty pharmacy industry to the benefit of everyone involved, from patients to nurses to payers to prescribers to hospitals. Today, we’re both celebrating our rapid progress toward achieving this vision and doubling down on our recent momentum with a series of announcements:
Together, these achievements strengthen our ability to move all the care that doesn’t need a hospital to the home. Here’s a closer look at what’s new for our network and why we’re more confident than ever in the future of on-demand specialty pharmacy.
We’ve always described ourselves as a marketplace built by nurses, for nurses. At a time when healthcare workers struggle to find safe, reliable, and empowering gig work, we’ve doubled down on deploying a nurse-first approach that prioritizes flexible schedules, enhanced compliance, and patient-centric care (more on this approach in our latest blog). Significant enhancements to our mobile application strengthen this commitment. New features in our nurse mobile app allow nurses to:
These updates weren’t created in a vacuum—they’re the direct result of ongoing feedback from our nurse community, which will continue to drive future updates.
Our tech-focused approach also streamlines how specialty pharmacies coordinate and deploy at-home care. These partners send home infusion patient referrals to Float, and we connect these patients with highly qualified nurses who deliver treatments in the comfort of patients’ homes. This approach makes routine medicine 12x cheaper than hospital-based alternatives while improving treatment adherence and reducing hospital admissions.
Today’s announcement includes an updated specialty pharmacy portal, which leverages AI to:
By centralizing all relevant information in one intelligent platform, we’ve eliminated the administrative nightmare of lengthy email chains, redundant communications, and chart bounceback—creating efficiencies that directly improve patient care and pharmacy operations.
Last year, we celebrated a $10M Series A funding round and expanded operations in California, Arizona, and Texas.
Now, at the end of Q1 2025, our numbers tell a compelling story:
In the next few months, we’re set to expand our operations to Florida—a state facing a projected shortage of approximately 60,000 nurses by 2035. We’re excited to hit the ground running and fill this gap with quality home-based care. More details to come!
Simultaneously, we’re also planning to partner with 20 new specialty pharmacies in Q2 of this year alone, further extending our reach and impact.
In the next few years, we’re committing to expanding to 25 states, providing more than 80% of people with chronic conditions access to quality at-home care and helping pharmacies nationwide retain patients, boost revenue, and access top nursing talent.
Chronic illness care—and specialty pharma as a whole—is primed for a transformation. At Float, we’re on a mission to ensure they change for the better with an innovative and empowering marketplace model that benefits everyone involved. The future of specialty pharma isn’t just bright. It’s being rewritten right now, and we’re honored to lead this historic shift in care delivery. For more information or to request a demo, visit floathealth.com.